Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for CANF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
December 31, 2023 9.989M
September 30, 2023 9.169M
June 30, 2023 11.03M
March 31, 2023 13.49M
December 31, 2022 9.283M
September 30, 2022 12.71M
June 30, 2022 14.75M
March 31, 2022 17.85M
December 31, 2021 20.25M
September 30, 2021 14.64M
June 30, 2021 9.68M
March 31, 2021 12.74M
December 31, 2020 9.523M
September 30, 2020 13.33M
June 30, 2020 12.80M
March 31, 2020 9.848M
December 31, 2019 8.175M
September 30, 2019 11.75M
June 30, 2019 13.67M
March 31, 2019 7.489M
December 31, 2018 7.952M
September 30, 2018 10.82M
June 30, 2018 10.98M
March 31, 2018 12.48M
December 31, 2017 7.614M
Date Value
September 30, 2017 8.762M
June 30, 2017 10.28M
March 31, 2017 12.24M
December 31, 2016 10.16M
September 30, 2016 11.83M
June 30, 2016 13.84M
March 31, 2016 16.52M
December 31, 2015 17.66M
September 30, 2015 15.23M
June 30, 2015 8.569M
March 31, 2015 9.920M
December 31, 2014 10.19M
September 30, 2014 4.867M
June 30, 2014 6.440M
March 31, 2014 8.758M
December 31, 2013 6.657M
September 30, 2013 3.246M
June 30, 2013 4.606M
March 31, 2013 5.956M
December 31, 2012 1.637M
September 30, 2012 2.553M
June 30, 2012 3.495M
March 31, 2012 3.715M
December 31, 2011 4.88M
September 30, 2011 1.378M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
BioLineRx Ltd. 38.80M
XTL Biopharmaceuticals Ltd. --
Kamada Ltd. 383.16M
Galmed Pharmaceuticals Ltd. 16.03M
Revium Recovery, Inc. 18.79M